[HS 592 (Tavegil) in the treatment of allergic manifestations in otorhinolaryngoiatry. Clinical contribution].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*
D006634:Histamine H1 Antagonists
L'HS 592 (Tavegil) nel trattamento delle manifestazioni allergiche in campo otorinolaringoiatrico. Contributo clinico.